About Beyond Antibody
Beyond Antibody is a Healthcare company based in Bengaluru (India) founded in 2015 by Sujan Kumar Dhar and Manjula Das. It operates as a bioservices company providing bioassays, drug testing, and characterization for biopharmaceuticals. It operates on a B2B model. Beyond Antibody offers products and services including Bioassays, Biophysical Characterization, and Recombinant Proteins. Its focus areas include Biotech, Bioservices, Bioassays and Drug Development. Its legal entity in India is Beyond Antibody Llp (AAG-1989). Its competitors include Reaction Biology, ImmunoSCAPE, PhenoVista, BCI Pharma and Quantumcyte and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Beyond Antibody is a bioservices firm that supports biopharmaceutical development by characterizing drug candidates through biophysical and pharmacological assays. They offer services like bioassays, recombinant proteins, and pre-clinical regulatory studies. Operating from Bangalore, India, they manage projects via a virtual lab model with partnering labs. Their core team handles end-to-end processes for clients in the biotech industry.
- Headquarters Bengaluru, India
- Founders Sujan Kumar Dhar, Manjula Das
- SectorsHealthcare
- Email••••••••
- Website beyondantibody.com
- Legal Name Beyond Antibody Llp
- Date of Incorporation 20 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of Beyond Antibody
Beyond Antibody operates through Beyond Antibody Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Beyond Antibody Llp CIN AAG-1989 | Active | 20 Apr 2016 | Bangalore, Karnataka | – | – | 2 | View details |
Products & Services of Beyond Antibody
Beyond Antibody offers a comprehensive portfolio of products and services, including Bioassays, Biophysical Characterization, and Recombinant Proteins.
Cell-based and in vivo assays for drug candidate testing.
Techniques like mass spectrometry for drug analysis.
Production of proteins for biopharmaceutical applications.
Board of directors of Beyond Antibody Llp (Beyond Antibody)
Beyond Antibody Llp is the primary company behind Beyond Antibody. The board of Beyond Antibody Llp currently have 2 directors; the longest-serving is Manjula Das, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manjula Das DIN 00940029 | Designated Partner | 20 Apr 2016 | 10 yrs 5 mo | Beyond Antibody Llp |
| Sujan Kumar Dhar DIN 00939916 | Designated Partner | 20 Apr 2016 | 10 yrs 5 mo | Beyond Antibody Llp |
People of Beyond Antibody
2 people are tracked at Beyond Antibody (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership | |
| Co-Founder, Managing Director | Leadership |
Complete people profiles for Beyond Antibody
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Beyond Antibody
Beyond Antibody has 10 listed competitors in our database, 6 of them funded. They include Reaction Biology, ImmunoSCAPE, PhenoVista, BCI Pharma and Quantumcyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reactionbiology.com | 2001 | United States | – | 77 | In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling | |
| immunoscape.com | 2016 | Singapore | $39M | – | High-dimensional immune profiling services are delivered via proprietary platform. | |
| phenovista.com | 2014 | San Diego, United States | $3M | 11 | A CRO that provides phenotypic assay development and screening services. | |
| bci-pharma.com | 2013 | Grabels, France | $4.7M | – | Contract research services in cancer and neuroinflammation are offered. | |
| quantumcyte.com | 2013 | Sunnyvale, United States | $1.3M | – | Drug assay systems for cancer treatment are developed and provided. | |
| discoverybiomed.com | 2007 | Birmingham, United Kingdom | – | – | Custom human cell engineering and drug discovery services are provided. | |
| ice-biosci.com | 2010 | Beijing, China | $14.03M | – | Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening | |
| radiantresearch.in | 2009 | Bengaluru, India | – | 34 | Preclinical in vitro testing and development services are offered. | |
| genoskin.com | 2011 | Toulouse, France | $5.4M | – | In vitro human skin models for preclinical toxicity and efficacy testing | |
| epithelix.com | 2006 | – | – | – | In-vitro 3D tissue models for respiratory drug testing are provided. |
Detailed competitors of Beyond Antibody
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Beyond Antibody (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Beyond Antibody
Beyond Antibody was founded in 2015.
Beyond Antibody is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Beyond Antibody is a bioservices firm that supports biopharmaceutical development by characterizing drug candidates through biophysical and pharmacological assays. They offer services like bioassays, recombinant proteins, and pre-clinical regulatory studies. Operating from Bangalore, India, they manage projects via a virtual lab model with partnering labs. Their core team handles end-to-end processes for clients in the biotech industry.
Beyond Antibody's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.
Beyond Antibody offers Bioassays, Biophysical Characterization, and Recombinant Proteins.
Beyond Antibody operates through Beyond Antibody Llp.
The legal entities of Beyond Antibody currently have 2 directors, including Manjula Das, Sujan Kumar Dhar.